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INTRODUCTION 
 
Periodontitis is a chronic infectious disease, triggered by the host immune response 
to an array of periodontal biofilm-associated microorganisms, which ultimately leads to the 
inflammation of the tissues supporting the teeth. 
The initial host response to bacterial infection is a local inflammatory reaction that 
activates the innate immune system. An imbalance between biofilms and immune system 
results in over expression of an array of pro-inflammatory cytokines, propagation of 
inflammation through the gingival tissues and subsequent destruction of alveolar bone. 
Thus, the inflammatory process results in destruction of connective tissue and alveolar 
bone – Hallmark of periodontal disease. 
Diagnosis of periodontal disease has been primarily based upon clinical and 
radiographic measures of periodontal tissue destruction. These parameters provide a 
measure of past destruction and are of limited use in early diagnosis (Frodge et al, 2008)
1
. 
Biomarkers of disease play an important role in life sciences and have begun to assume a 
greater role in diagnosis, monitoring of therapy outcomes, and drug discovery (Teles et al, 
2010)
2
. For biomarkers to assume their rightful role in routine practice, it is essential that 
their relation to the mechanism of disease progression and therapeutic intervention be more 
clearly understood. 
One of the biomarkers of alveolar bone destruction is osteopontin. Osteopontin 
(OPN) is a non-collagenous, calcium binding, glycosylated phosphoprotein produced by 
osteoblasts (Rodan, 1994)
3
. Osteopontin level reflects active lesions of aggravated 
periodontal disease accompanied by alveolar bone resorption. The concomitant increase of 
osteopontin in plasma is caused by spillage or overflow of osteopontin from the diseased 
periodontal tissues or produced by circulating activated macrophages. The level of 
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osteopontin before and after treatment can be used to assess the severity of periodontal 
disease. 
Treatment of periodontal disease includes both non-surgical and surgical therapy. 
Non-surgical therapy remains the corner stone of periodontal treatment. It includes scaling 
and root planing under local anaesthesia to provide patient comfort and to control the 
disease progression. Systemic therapy may be employed as an adjunct to local measures 
and for control of systemic complications. 
Homeopathy is a system of alternative medicine that was introduced by German 
physician and scientist Dr Samuel Hahnemann in 1796. It is based on the principle of 
‘similia similibus curentur’ (like cures like) (Lessell, 1995)4. This means that the 
medicines used are derived from substances that if taken by a healthy person can cause 
symptoms similar to the illness, but when taken by the patient they trigger the body’s 
natural healing process. Homeopathy is recognised by the World Health Organization 
(WHO) as the second largest system of medicine in the world today. The medicines used 
can be in both low and ultra-molecular dilution but both clinical experience and evidence 
suggest that they are still effective. 
Homeopathic remedies are based on a holistic approach to health that addresses 
illness by stimulating the body’s own healing powers. Some investigators have proved that 
homeopathic drugs can be used as an adjunct to nonsurgical therapy in dentistry. So, the 
present study is to investigate the effectiveness of homeopathic drug, calcarea fluor, as an 
adjunct to non-surgical therapy in the treatment of chronic periodontitis. 
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AIM 
To evaluate the efficacy of calcarea fluorica ( 30c)  as an adjunct to non-surgical 
periodontal therapy . 
 
 
 
 
 
OBJECTIVES 
 
 To compare the clinical parameters before and after the treatment in each group. 
 To compare the clinical parameters between different groups. 
 To compare osteopontin level in plasma in each group before and after treatment. 
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REVIEW OF LITERATURE 
 
 Periodontal disease is characterized by tissue inflammation and destruction of the 
tooth supporting structures that eventually leads to the loss of affected teeth (Kinane 2001, 
Page & Kornman 1997, Philstrom et al. 2005)
5,6,7
. Despite our increased understanding of 
the etiology and pathogenesis of periodontal infections, the diagnosis of these diseases is 
still based almost entirely on traditional clinical assessment ( Armitage 1995)
8
. To arrive at 
a periodontal diagnosis, the dentist must rely upon factors such as (a) presence and absence 
of signs and symptoms, including pain, ulceration and amount of observable plaque and 
calculus (b) patients medical and dental history (c) presence or absence of clinical signs of 
inflammation like bleeding on probing (d) probing depths and (e) extent and pattern of 
clinical attachment and bone loss. These parameters provide a measure of past destruction 
and are of limited use in early diagnosis (Frodge et al,2008)
1
. Because of the increasing 
prevalence and associated comorbidities, screening and diagnostic modalities for the early 
identification of periodontitis, its initiation and progression, as well as objective measures 
for response to therapy, are being sought. ( Beck et al 2005, Genco et al 2001, Seymour et 
al 2007, Mealey & Oates 2006 )
9,10,11,12
. 
 
Osteopontin: 
 A periodontal diagnostic tool provides pertinent information for differential 
diagnosis, localization of disease, and severity of infection. These diagnostics, in turn, 
serve as a basis for planning treatment and provide a means for assessing the effectiveness 
of periodontal therapy (Taba et al 2005)
13
. In the disease process, potential biomarkers of 
the disease activity would need to be involved in some way in the disease process or 
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released as a consequence of tissue damage during disease progression. A biomarker is an 
objective measure that has been evaluated and confirmed either as an indicator of 
physiologic health, a pathogenic process, or a pharmacologic response to a therapeutic 
intervention.  
Osteopontin (OPN)- a bone related biomarker, is a non-collagenous, calcium 
binding, glycosylated phosphoprotien produced by osteoblasts. OPN is important in 
immune activity and bacterial resistance and was named early T-lymphocyte activation 1 
protein (Eta-1) by Patarca et al in 1989
14
. Today the protein is designated as OPN and is 
known to be involved in bone resoption, wound repair, immune function , cell survival and 
cancer biology. 
 Bone remodelling is a regulated process in which removal of old bone by 
osteoclasts is followed by bone formation by osteoblasts. OPN influences bone hemostasis 
both by inhibiting mineral deposition, by promoting differentiation of osteoclasts and by 
enhancing osteoclastic activity. (Standal et al 2004 )
15
. 
Bone matrix consists of an inorganic component in the form of hydroxyapatite and 
an organic component consisting of proteins and proteoglycans. OPN is a major non-
collagenous protein in bone. Its electronegative glutamic and aspartic acid residues as well 
as the putative Ca
2+
 binding motif make it bind tightly to hydroxyapatite. OPN is a major 
inhibitor of the mineralization process, since binding of OPN to hydroxyapatite  inhibit the  
growth of  hydroxyapatite crystals. ( Steitz SA et al 2002, Hunter et al 1996, Pampena et 
al 2004)
16,17,18
. 
Osteoclasts develop from precursor cells in monocyte/macrophage family to 
become giant multinucleated cells capable of resorbing bone. The maturation and 
differentiation of macrophages to osteoclasts are dependent on two factors secreted or 
expressed by stromal cells/ osteoblasts : (i) macrophage colony stimulating factor and 
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(ii)receptor for activation of NF-kB ligand ( RANKL) (Teitelbaum 2000)
19
.  Engagement 
of theses cytokines with their receptors on the osteoclast precursor cells induces maturation 
of osteoclast. . Osteoprotegerin (OPG) is a decoy receptor for RANKL. It is secreted by 
osteoblasts / stromal cells and inhibits the interaction of RANKL with RANK and thereby 
inhibits osteoclastogenesis. 
OPN does not seem to be an essential factor in the development of osteoclasts 
during normal bone development since osteoclast number and distribution are normal in 
OPN knock-out mice (Rittling et al 1998, Liaw et al 1998)
20,21
. However, several studies 
show that in pathological conditions, OPN is of importance in osteoclastogenesis. 
Parathyroid hormone induced RANKL signalling normally results in either an increase in 
osteoclast number and/or activation , but this increase is disrupted in the absence of OPN   
(Ihara et al 2001)
22
. Neutralization of OPN suppresses osteoclastogenesis , whereas 
addition of OPN enhances osteoclastogenesis ( Yamate et al 1997, Ishii et al 2004)
23,24
. 
OPN stimulate osteoclast migration (Faccio et al 1998, 2002, Chellaiah & Hruska 
2003)
25,26,27
. Osteoclasts deficient in OPN do not migrate and are unable to resorb bone 
(Chellaiah & Hruska 2003, Tani-Ishii et al 1997)
27,28
. 
In mineralized tissue, OPN is secreted by both osteoclasts and osteoblasts (Yamate 
et al 1997, Dodds et al 1995, Merry 1993)
23,29,30
. It is an inflammatory mediator whose 
levels are found to commensurate with the progression of periodontal disease in gingival 
crevicular fluid and in plasma. The concomitant increase in plasma is caused by spillage or 
overflow from the diseased periodontal tissues or produced by circulating activated 
macrophages ( Sharma CG and Pradeep AR 2007)
31
. Sharma reported that osteopontin 
(OPN) concentrations increased proportionally with the progression of disease and when 
nonsurgical periodontal treatment was provided, GCF and plasma OPN levels were 
significantly reduced. 
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Non-surgical therapy: 
 The main goal of the treatment of patients with periodontitis is to establish proper 
infection control, i.e, to reduce the bacterial load below the individual threshold level for 
disease. Cause-related periodontal therapy is usually the initial phase of periodontal 
treatment. The aims are to eliminate supra- and sub-gingival bacterial deposits and 
to prevent their recurrence (Haffajee et al. 1997)
32
. Even in the most severe cases of 
periodontal disease, cause-related periodontal therapy most often precedes surgical 
therapy. This is done so that the active periodontal infection is reduced and the 
overall tissue quality is improved prior to surgery. This procedure may also limit the 
areas requiring surgery. 
 
 
The aims can be achieved by the following procedures/measures: 
- Motivate the patient to understand periodontal disease and the importance of co-
operation in order to combat the disease. Optimal treatment results and stable long 
term conditions depend on optimal self-performed oral hygiene and compliance 
towards regular maintenance visits. 
- Provide the patient with custom-made oral hygiene instruction and reassess the 
results from time to time and reinforce the technique, if necessary. Maintaining 
optimal personal hygiene is paramount because at least one study showed that 
instrumentation alone without improving patient’s plaque control may lead to 
microbial repopulation of the instrumented sites shortly after scaling and root 
planing (Magnusson et al. 1984)
33
. 
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 Non-surgical periodontal therapy include scaling and root planing to remove 
bacterial plaque and calculus subgingivally by mechanical means, using either manual 
instruments such as hand scalers/curettes or machine-driven instruments such as sonic or 
ultrasonic scalers.  Badersten et al ( 1981)
34
, Torfason et al (1979)
35 
 have shown that both 
instrumentation approaches could achieve similar results, but according to Leon & Vogel 
(1987)
36
 ultrasonic instruments might be more suitable in furcation areas.  
Although the word “planing” means to remove substance for achieving a smooth 
surface, Nyman et al  (1988)
37
 showed that it was not necessary to plane the root surfaces 
until smooth or to remove the so called “diseased/ contaminated” cementum.  A clinical 
study by Oberholzer & Rateitschak 1996
38 
concluded that the establishment of a smooth 
and hard root surface was not a critical factor in periodontal therapy. 
Non-surgical treatment improves clinical parameters including bleeding on 
probing, probing depths and probing attachment levels, provided that patients can obtain 
and maintain a proper plaque control . 
Singletary et al 1982
39
, Greenewell et al 1984 
40
, Lavanchy et al 1987 
41
 reported a 
significant reduction in gingival inflammation 1-3 months after phase I therapy. Hughes & 
Caffesse 1978 
42
demonstrated that reduction of probing depth following mechanical 
instrumentation results from a combination of gain in clinical attachment and increase in 
gingival recession . Proye et al 1982 
43
 noted recession after one week and a gain of 
clinical attachment by 3 weeks after phase I therapy. After a single episode of scaling and 
root planing, pockets were reduced to 1.36 mm. This consisted of 0.84 mm recession and 
0.52 mm attachment gain. 
Morrison et al 1982 
44
 in another examination of data from the previously 
mentioned 8-year longitudinal study analyzed the effect of gingivitis scores on probing 
depth and attachment levels. For pockets 1 to 3 mm and 4 to 6 mm there was no difference 
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in pocket reduction maintenance. For attachment there was no difference in 1 to 3 mm 
probing depths and in 4 to 6 mm pockets, lower gingivitis scores had better gain the first 2 
years but thereafter no difference was recorded. For 7 to 12 mm pockets, the lower 
gingivitis scores seemed to result in better probing levels and attachment gain for the first 3 
years but this was not maintained throughout the experiment. The severity of gingivitis did 
not affect the maintenance of pocket depth reduction or clinical attachment levels. 
Ramfjord et al 1982 
45
 reported that deepest sites demonstrated the greatest pocket 
reduction after instrumentation. They conducted a study in pockets with 1-3mm, 4-6mm 
and ≥7mm for 5years and found the greatest pocket reduction in group with ≥7mm pocket 
depth. But they also found a greater amount of recession in this group. 
Cobb 1996 
46 
reported that for shallow pockets with initial probing depth 1-3mm, 
the mean reduction of probing pocket depth (PPD) was 0.03mm and loss of probing 
attachment level (PAL) was 0.3mm. For  moderate pockets with initial PPD of 4-6mm, the 
mean reduction of PPD was about 1.29mm and the PAL gain was 0.55mm . For deep 
pockets with initial PPD ≥ 7mm, the mean reduction of PPD was about 2.16mm and the 
PAL gain was 1.19mm . 
The number of sites that bleed on probing also markedly reduces following 
nonsurgical therapy. Cobb (2002)
47
 reviewed many studies and found that the mean 
reduction in bleeding on probing from baseline levels was about 45%.  
Non-surgical periodontal therapy has been proved to be effective in controlling the 
disease in most patients (Badersten et al. 1984, Claffey & Egelberg 1995)
48,49
. 
Furthermore, most of the stabilized periodontal conditions can be maintained throughout 
time if the patients are committed to have supportive periodontal care (Axelsson & Lindhe 
1981, Renvert & Persson 2004)
50,51
. 
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Philstrom et al. (1981)
52
, in a 4-year study utilizing multi-rooted teeth, compared 
scaling and root planing to modified Widman surgery. Seventeen patients received 
thorough scaling and root planing as well as oral hygiene instructions. A modified Widman 
flap was then performed on one half of each subject's dentition. Patients were recalled 3 to 
4 times a year for 4 years. The data were separated into 3 groups by initial pocket depth; 1 
to 3 mm, 4 to 6 mm, and > 7 mm. Both methods resulted in increased probing depth and 
loss of attachment in the 1 to 3 mm group, in the 4 to 6 mm group both procedures resulted 
in reduction in probing depth and maintenance of attachment levels with the root planing 
resulting in slightly more gain in attachment. The > 7 mm group showed the greatest 
reduction in probing depth and gain in attachment with better results in the flap procedures. 
The results indicate that both procedures were effective in treating moderate to advanced 
periodontitis. The additional flap procedure tended to result in greater probing reduction 
and attachment gain for deeper pockets.  
Philstrom et al. (1983)
53
 in a second report analyzed the 6.5 year results of the 
previous study. This report concludes that scaling and root planing alone or in combination 
with modified Widman flap surgery resulted in sustained decreases in gingivitis, plaque, 
and calculus and neither procedure appears to be superior with respect to these parameters. 
Seventeen  patients diagnosed with moderate-advanced periodontitis were utilized in a 
split-mouth design study to compare the effects of scaling and root planing alone and 
combined with modified Widman flap surgery. Data were collected at baseline, 6 months 
following active therapy and every year up to 4 years, then at 5 1/2 and 6 1/2 years. 
Probing depth did not change for 1 to 3 mm pockets treated by either scaling and root 
planning alone or in combination with modified Widman flap surgery. For pockets 4 to 6 
mm, both treatment procedures resulted in equally effective sustained pocket reduction. 
Deep pockets (> 7 mm) were initially reduced more by the flap procedure. After 2 years, 
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no consistent difference between treatment methods was found in degree of pocket 
reduction. For pockets initially 4 to 6 mm in depth, attachment level was maintained by 
both procedures. Pockets > 7 mm in depth treated by either procedure resulted in a 
sustained gain in attachment. 
 Philstrom et al. (1984)
54
 in a third report examined the response of molar and non-
molar teeth to scaling and root planing alone or scaling and root planing plus a flap 
procedure. At 6 1/2 years, non-molar teeth had an average of about 1.0 mm less probing 
depth than molar teeth irrespective of type of procedure performed. There was greater 
probing depth and more apical attachment level on molar than on non-molar teeth treated 
by either method for 4 to 6 mm pockets. In > 7 mm pockets, the flap resulted in less pocket 
depth on non-molars than molars, but no difference in the attachment level for either 
method. Nineteen of the 453 teeth included in the study were extracted throughout the 
study; 11 of these were extracted after therapy. 
 Hill et al. (1981)
55
 published a 2-year study of scaling and root planing compared 
to modified Widman surgery. This 90-patient study included multi-rooted teeth. Following 
a hygienic phase which included scaling and root planing and oral hygiene instructions;, 
each quadrant was treated by 1 of 4 treatments (pocket elimination, modified Widman flap 
(MWF), subgingival curettage, and scaling and root planing). Measurements which 
included pocket depth and attachment levels were taken at the initial exam, after the 
hygienic phase and 1 and 2 years after treatment. In the 1 to 3 mm crevices there was a 
slight loss of attachment after all types of treatments. In the 4 to 6 mm pockets there was a 
significant reduction in probing depth after all modalities with the greatest reductions after 
pocket elimination and modified Widman flap, and a loss of attachment for pocket 
elimination and a gain for curettage and scaling. In the > 7 mm pockets there was a 
significant reduction after all modalities with the greatest reduction after pocket 
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elimination, and no significant differences in attachment results among the 4 methods. 
None of the surgical modalities had any better effect than scaling and root planing alone in 
maintenance of periodontal support which was not directlyrelated to reduction in pocket 
depth. 
 Lindhe et al. (1982A)
56
 reported results of a 2-year study of 15 patients comparing 
scaling and root planing to modified Widman surgery. Mutilated  teeth were included in 
this study. Patients with advanced periodontal disease were entered into a split mouth 
design to compare the results of subgingival debridement performed  in conjunction with a 
modified Widman flap or scaling and root planning alone. Scaling and root planing took 6 
to 8 hours over a 4- week period. Oral hygiene and the gingival condition in both groups 
improved significantly. Both treatments resulted in a decrease in probing depth. Initial 
values were 4.2 and 4.1 mm and decreased to 2.4 and 2.5 (surgery) and 2.9 and 2.8 mm (no 
surgery). Attachment levels improved following non-surgical therapy at 6 and 12 months, 
but at 24 months returned to baseline values. Surgical treatment resulted in a slight loss of 
attachment of 0.3 mm. When comparing single-rooted to multi-rooted teeth, there was a 
trend for slightly better results for single-rooted teeth. These similar results can be 
maintained over time in patients with proper oral hygiene levels. 
 Lindhe et al. (1982B)
57
 in another report from the previous study determined the 
critical probing depth for scaling and root planing and modified Widman surgery. Probing 
depths shallower than the critical probing depth tend to lose attachment following the 
procedure. The results showed that the critical probing depth for the scaling and root 
planing group was 2.9 mm ± 0.4 and for the modified Widman’s group was 4.2 mm ± 0.2 
which indicates that in patients with a large number of shallow probing depths, a non-
surgical approach is preferable, while in patients with a large number of pockets > 4.2 mm, 
surgical treatment may result in more gain of attachment. The results also showed that the 
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level of oral hygiene established during healing and maintenance is more critical for the 
resulting probing depths and attachment levels than the mode of treatment used. 
 Lindhe et al. (1984)
58 
 reported 5-year results of a continuation of the previous 
study. The results showed that patients who maintained good oral hygiene had more 
reduction in probing and a greater gain in attachment than patients who failed to perform 
good plaque control, indicating that the patients' self-performed plaque control had a 
decisive influence on the long-term effect of treatment. Sites with initial probing depth 
exceeding 3 mm responded equally well to non-surgical and surgical treatment. 
 Isidor et al. (1984)
59
, in a 6-month study on single-rooted teeth, compared 3 
treatments utilizing a split-mouth design: Scaling and root planing versus modified 
Widman surgery versus reverse bevel flap. Seventeen patients were treated for advanced 
periodontitis. One side of both the maxilla and the mandible were treated with modified 
Widman flap. On the other side, one quadrant was treated with reverse bevel flap surgery 
without osseous recontouring, and the last quadrant was treated with scaling and root 
planing alone. Patients were recalled every 2 weeks, and examination was performed at 3 
and 6 months after the completion of treatment. At 6 months scaling and root planing 
resulted in considerable reduction in pocket depth, but more shallow pockets were obtained 
following surgical treatment. Clinical gain of attachment was obtained following all 3 
modalities but scaling and root planing resulted in slightly more gain of attachment than 
the 2 surgical procedures. 
Isidor et al. (1985)
60 
 reported 1-year results of the previous study. Lateral incisors, 
canines, and premolars in the maxilla and mandible in 16 patients diagnosed with advanced 
periodontitis were used for study. Each patient was then treated with reverse bevel flap 
surgery in 1 quadrant, modified Widman flap surgery in 2 quadrants, with the fourth 
quadrant treated with scaling and root planing. They were then recalled every second week 
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for professional tooth cleaning. The plaque index and bleeding on probing were assessed 
prior to and 3, 6, and 12 months after treatment. Probing depths and clinical attachment 
levels were assessed prior to and 1 year after treatment. Radiographs were taken using the 
bisecting angle technique before and 1 year after treatment, and the bone level was 
expressed as a percentage of the distance from the apex of the tooth to the normal bone 
level. Angular bony defects corresponding to 15% or more of the distance between the 
normal level of the bone and the apex of the involved tooth were located. The results of 
this study indicate that when comparing modified Widman flap surgery, reverse bevel flap 
surgery, and scaling and root planing for regeneration of alveolar bone, only the modified 
Widman flap surgery resulted in significant coronal regrowth of bone in angular bony 
defects. 
 Isidor and Karring (1986)
61 
 reported 5-year results of the previous studies. Sixteen 
patients with advanced periodontitis were subjected to supra- and subgingival scaling and 
oral hygiene instructions. This was followed by modified Widman flap, reverse bevel flap, 
or scaling and root planing. Patients were then recalled regularly for the next 5 years 
Surgical and non-surgical treatment resulted in pocket reduction which was maintained 
over the 5 years. All methods were effective in halting the progression of periodontitis. No 
correlation was found between oral hygiene and recurrence of periodontitis, suggesting 
subgingival scaling at frequent recalls is an important factor in halting the progression of 
disease. 
 Becker et al. (1988)
62
 reported 1-year results of a study comparing scaling and root 
planing, modified Widman surgery, and osseous surgery utilizing a split mouth design. The 
study population consisted of 16 patients with 2 or more sites with > 6 mm of clinical 
attachment loss in the posterior dentition. All patients had a baseline examination including 
the plaque index, gingival index, probing depth, clinical attachment levels, mobility, and 
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furcation status. The probing depths were classified as 1 to 3 mm; 4 to 6 mm; or > 7 mm. 
The clinical attachment level measurements were classified as 0 to 2 mm; 3 to 5 mm; and > 
6 mm. Quadrants were randomly assigned to 1 of 3 treatment groups: scaling and root 
planing, modified Widman flap surgery, or osseous surgery. At 1 year post-treatment, 
osseous and modified Widman surgery had significantly greater probing reduction when 
compared to scaling and root planing. For pockets > 7 mm, osseous and modified Widman 
surgery had significantly greater reduction when compared to scaling and root planing. For 
pockets 1 to 3 mm, osseous surgery had significantly greater clinical attachment loss when 
compared with scaling and root planing. The results indicate that at 1 year, scaling and root 
planing, osseous surgery, and the modified Widman procedure were equally effective in 
treating moderate to advanced periodontitis. 
Kerry et al. (1990)
63
 reported 5-year probing depth results of the previous study. 
Sixteen patients with moderate periodontitis were treated in private practice by 
periodontists highly competent in performing scaling and root planing, modified Widman 
flap, and osseous surgery. Patients were evaluated for 5 years. At the 5-year evaluation, 
plaque and gingival indices were reduced and maintained throughout the study with no 
difference between treatment methods; 1 to 3 mm probing depths increased insignificantly 
but were stable at 3 years; 4 to 6 mm pockets were reduced significantly, but diminished 
over time. There was a difference between scaling and root planing compared to osseous 
surgery at 3 and 4 years, but not at 5. Similar trends were found for > 7 mm pockets. All 3 
procedures reduced pocket depth significantly, with no difference between procedures 
at 5 years. 
 Becker et al. (1990)
64
 reported 5-year attachment level and gingival recession 
results of the previous studies. Sixteen  patients were treated for moderate periodontitis 
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with either scaling and root planing, modified Widman flap, or osseous surgery. Evaluation 
were made after the hygienic phase, postsurgery, 6 weeks, 6 months, and at yearly intervals 
for 5 years. Pockets 1 to 3 mm showed significant loss of attachment; 4 to 6 mm pockets, 
as well as > 7 mm pockets, showed an insignificant gain of clinical attachment with no 
difference among procedures. All procedures produced significant recession postsurgery. It 
was concluded that all techniques behave similarly regarding clinical attachment 
levels and gingival recession. 
 Kaldahl et al. (1988)
65 
reported 2-year results of a split mouth design study of 
multi-rooted teeth that compared supragingival scaling to subgingival scaling to modified 
Widman surgery to osseous surgery. Eightytwo  patients with moderate to advanced 
periodontitis had each of 4 quadrants randomly assigned to receive coronal scaling , 
subgingival scaling and root planning , root planing plus modified Widman flap, flap with 
osseous resection. Approximately 20% of the scaling teeth were retreated. The osseous 
resection group showed the greatest reduction in probing depth followed by modified 
Widman, subgingival scaling and root planing, and coronal scaling. In deep sites modified 
Widman, subgingival scaling and root planing , and osseous resection demonstrated the 
largest gain in attachment while coronal scaling was the least. 
Kaldahl et al. (1990)
66 
 reported 2-year results of the previous study that compared 
the site response. Eighty-two patients with moderate to advanced periodontitis were treated 
in a split mouth design with coronal scaling , root planing , modified Widman flap , and 
flap with osseous resection , followed by maintenance treatment for 2 years. Four tooth/site 
groupings were evaluated: 1) interproximal sites of single- rooted teeth (Tl); 2) facial and 
lingual sites of single-rooted teeth (T2); 3) nonfurcation sites of molar teeth (T3); and 4) 
furcation sites of molar teeth (T4). The sites were further subdivided by their initial 
probing depth severity (1 to 4 mm, 5 to 6 mm, and > 7 mm). The results showed that 
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single-rooted sites > 5 mm had a greater mean probing depth reduction and greater probing 
attachment gain than did the molar sites. Furcation sites showed a greater increase in 
probing depth and loss of attachment during the 2 years of maintenance. No therapy had a 
distinct advantage over another in enhancing the relative response of a particular tooth/site 
group to the other groupings. 
 Kalkwarf et al. (1992)
67 
 reported 2-year results of the 2 previous studies that 
analyzed patient preference of treatment method. Seventy-five patients were evaluated 
using an interview after 3 years of maintenance care. Each quadrant in each subject was 
randomly assigned to 1 of 4 types of periodontal therapy: 1) coronal scaling; 2) coronal 
scaling plus subgingival scaling and root planing; 3) coronal scaling / scaling and root 
planning followed by modified Widman surgery ; or 4) Coronal scaling/ scaling and root 
plaing followed by flap with osseous resectional surgery. During the hygienic phase of 
therapy, patients were instructed in plaque control and teeth were instrumented with sealers 
and currettes. Maintenance therapy was performed at 3-month intervals by a dental 
hygienist. At the conclusion of 3 years of maintenance care, a 7 question interview was 
conducted with each patient to obtain perceptions regarding the results of therapy in each 
region of their mouth. The results of this study indicate that the ability of the patient to 
cope with post-therapy sequelae following either coronal scaling, root planing, modified 
Widman surgery, or flap with osseous resectional surgery is not significantly different. 
 Cercek et al. (1983) 
68 
reported results of a 2-year study that compared 
supragingival plaque control to subgingival plaque control to scaling and root planing. 
Seven patients with chronic periodontitis were monitored during 3 phases of treatment: 1) 
tooth brushing and flossing; 2) Perio-Aid used subgingivally; and 3) subgingival 
debridement. Plaque scores ranged from 38 to 99% with a mean of 74% at the initial exam. 
These scores were reduced to 5 to 15% and were maintained throughout the study. The 
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mean bleeding score of 71.7% was reduced to 40.9% in Phase I, no change in Phase II, and 
reduced to 23% in Phase III. Deeper sites showed more bleeding than shallower sites 
throughout the study. The mean probing depth of 4.4 mm was reduced to 4.0 mm in Phase 
I, no improvement in Phase II, and reduced to 3.2 mm after instrumentation. Probing 
attachment level showed a slight loss through Phase II, but improved attachment levels 
were found after instrumentation. An increasing gingival recession was noted during the 
study. Minimal effect was derived from patient-performed plaque control, whether supra- 
or subgingival. The bulk of the effect was derived from professional subgingival 
instrumentation (SRP). 
 Badersten et al. (1981)
34 
in a 13-month study of patients with moderate 
periodontitis compared the effect of hand versus ultrasonic instrumentation on attachment 
levels of single-rooted teeth. Incisors, canines, and premolars in 15 patients with 
moderately advanced periodontitis were treated by hand and ultrasonic non-surgical 
therapy. Improvements in plaque scores, bleeding on probing, decreased probing and 
attachment levels were similar for both treatment methods. It was shown that shallower 
sites had a slight loss of attachment while deeper sites showed some improvement. 
Badersten et al. (1984A)
48 
 reported 24-month results of a study comparing hand to 
ultrasonic instrumentation in patients with severe periodontitis. Sixteen patients with 
severely advanced periodontal disease were treated by hand or ultrasonic non-surgical 
therapy. Comparable results were obtained by both methods. It was shown that the deep 
probing depths could be successfully treated non-surgically based on probing depth, 
probing attachment levels, bleeding on probing, plaque, and gingival recession. It was 
shown that shallower sites were at risk of losing attachment, while the deep sites were 
more likely to gain attachment. Deeper residual probing sites were more likely to bleed on 
probing. 
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Badersten et al. (1984B)
69
 compared the effect of a single session of scaling and 
root planing to repeated sessions of scaling and root planing. Incisors, canines, and 
premolars were studied in 13 patients with severe periodontitis. Teeth were instrumented 
using ultrasonic instruments, and repeated instrumentation in one side of the jaw was 
performed after 3 and 6 months. A gradual and marked improvement took place during the 
first 9 months. No differences in results could be observed when comparing the effects of a 
single versus repeated instrumentation. Deep periodontal pockets in incisors, canines, and 
premolars may be treated by plaque control and one episode of instrumentation. 
Badersten et al. (1985A)
70 
 reported a study of the effect of operator variability on 
the results of the scaling and root planing procedure. Twenty patients whose dentition 
displayed generalized severe periodontal destruction were selected for the study. The 
incisors, canines, and premolars in either the maxilla or the mandible were studied. The 
periodontal pockets were debrided using either hand and/or ultrasonic instruments under 
local anesthesia by a periodontist or by 1 of 5 dental hygienists. A split mouth design was 
used with measurements of dental plaque, bleeding on probing, probing depth, and probing 
AL recorded at the initial exam and at every third month by an examiner not involved with 
treatment. The results indicate that deep periodontal pockets in incisors, canines, and 
premolars may be successfully treated by plaque control and one episode of 
instrumentation and that operator variability between highly skilled clinicians is minimal. 
Badersten et al. (1985B)
71 
 examined patterns of probing attachment loss following 
scaling and root planing. Incisors, canines, and premolars in 33 patients with generalized 
periodontal destruction were studied for patterns of probing attachment loss. Patients 
received supra- and subgingival debridement after oral hygiene instructions, and were 
followed for 24 months. Measurements were made every third month and 7 patterns of 
probing attachment were identified. Seventy-three percent (73%) of sites showed a gradual 
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change. Seventeen percent (17) showed an early loss followed by a stabilization of 
attachment levels. Shallower sites showed a pattern of early loss followed by stabilization 
while deeper sites showed a gradual loss. 
In general, clinicians should assess healing four to six weeks after performing root 
planning (AAP 1989)
72
. Cercek and coworkers ( 1983)
68 
 noted clinical improvements 
continued for 8 months, however, most of the healing occurred during the first month.  
Similarly, Kaldahl and colleagues (1988)
65
 demonstrated that the repair process 
extended for 1 year. It appears that the greatest changes with respect to probing depth 
reduction and gain of clinical attachment can be recorded after 4 to 6 weeks, but gradual 
repair and maturation of the periodontium may occur over 9 to 12 months. 
Longitudinal studies by Ramfjord et al (1982)
45 
 indicated that scaling and root 
planing arrested attachment loss as well as surgical therapy regardless of probing depths. 
However, information relating to length of therapy, skill level of therapists, compliance of 
patients with recall intervals and plaque control, responsibilities of clinicians for long-term 
maintenance and disease activity status need further clarification. Concerns regarding these 
issues must be integrated into therapeutic decisions, because they can dramatically affect 
interpretation and application of reported data. 
 
Homeopathic medicine : 
Non-surgical therapy remains the corner stone of periodontal treatment. But 
complementary and alternative therapies have gained popularity among patients in the 
recent years. Complementary medicine is based on the perspective that everything, 
including our bodies, is balanced and any disturbance—be it mental, emotional or 
physical—can cause a diseased state. One such system of alternative medicine is 
homeopathy. 
Review of Literature 
 
 Page 21 
 
 Homeopathy is a system of alternative medicine originated in 1796 by Samuel 
Hahnemann, based on his doctrine of similia similibus curentur ("like cures like"), 
according to which a substance that causes the symptoms of a disease in healthy people 
will cure similar symptoms in sick people ( Lessell 1995)
4
. 
 Hahnemann believed that the underlying causes of disease were phenomena that he 
termed miasms, and that homeopathic remedies addressed these. The remedies are 
prepared by repeatedly diluting a chosen substance in alcohol or distilled water, followed 
by forceful striking on an elastic body, called succession ( Lessell 1995, Dana Ullman 
1991) 
4,73 
.  Each dilution followed by succussion is said to increase the remedy's potency. 
Dilution usually continues well past the point where none of the original substance 
remains. Homeopaths select remedies by consulting reference books known as repertories, 
considering the totality of the patient's symptoms as well as the patient's personal traits, 
physical and psychological state, and life history (Dana Ullman 1991)
73
. 
 Conventional therapy believes that symptoms of an illness are a direct result of that 
illness and tries to suppress them with the medicine whereas homeopathy sees symptoms 
as the body’s attempt to overcome the illness and seeks to support this process with the 
remedy, and not to suppress it. Homeopathic remedies are based on a holistic approach to 
health that addresses illness by stimulating the body’s own healing powers. The idea 
behind homeopathic medicine is similar to that of getting a vaccination. 
The scope for homeopathy in dental practice is wide ranging. Homeopathy is used 
as an effective adjunct to dental surgery to help alleviate associated pain, bleeding and 
inflammation. At a more advanced level homeopathy can be used in dental practice to: 
-  Prevent or inhibit the development of morbid processes in the oral cavity 
-  Provide adjunctive treatments for a number of defined oral pathologies 
-  Prevent, limit or ameliorate complications and sequelae of surgical intervention 
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-  Ameliorate dental and soft tissue pain 
-  Assuage dental phobias and anxieties 
-  Improve patient tolerance of medications 
-  Facilitate recovery from dental trauma, restorative treatments and anaesthetic 
agents. 
Constitutional homeopathic prescribing involves analyzing a person’s body type, 
temperament, disposition and behavioural tendencies. Pathological prescribing is a 
treatment specifically for the disease or ailment. Homeopathy in dentistry offers a 
combination of these. It is possible to prescribe one medicine to suit the general 
temperament or psychological state of a patient and another for the particular problem 
the patient is experiencing. This is of particular value when using homeopathic 
medicines as an adjunct in the treatment of complex chronic dental pathologies, such as 
periodontal disease, TMJ dysfunction or Lichen planus. 
There are homeopathic medicines for every facet of dental prescribing, and some 
are specific to certain oral conditions. Homeopathy is not a replacement for the skills used 
in everyday dental procedures but is a useful complement, particularly in helping 
apprehensive patients to make dental treatment more acceptable and comfortable. They are 
safe, nontoxic and non-addictive and produce no known side-effects or interaction with 
conventional medicines. Consequently, homeopathic medicines can be taken with 
conventional drugs, by children and during pregnancy. Homeopathic medicines come in 
different forms including tablets, powders, pills, drops, liquids, tinctures, granules and 
creams. They are generally administered in one of two ways. Systemic administration 
involves dissolving the medicine either on or under the tongue from where it is rapidly 
absorbed. The dose is normally one or two tablets. The tablets should never be handled, as 
the medicine is impregnated on the surface of the tablets. Alternatively, the tablets can be 
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tipped from the cap of their container directly into the mouth and sucked or chewed. ( 
Peter Darby, 2011)
74
. At present there is no complete explanation of how homeopathic 
medicines work, but scientific interest in ultra-molecular dilutions is increasing and there is 
a growing body of evidence suggesting ultra-molecular solutions can exert biological 
effects (Linde et al, 1994; Belon et al, 2004; Witt et al, 2007)
75,76,77
. 
 Calcarea fluorica is a homeopathic medicine with chemical union of lime and 
fluoric acid which gives a remedy with a new nature and properties. However conversant 
one may be with either or both of these elements, the curative powers held in this double 
remedy cannot be predicted. It is used in case of unnatural looseness of teeth, with or 
without pain; teeth becoming loose in the sockets and in case of toothache if any food 
touches the tooth. ( W Boericke, 2000)
78
. This medicine has been used previously in dental 
field to check the remineralization efficacy on artificial carious lesions on enamel ( Bansal 
et al, 2014)
79
. But the present study is the only study till date to access the effectiveness of 
calc-f tablets on periodontium. 
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MATERIALS AND METHODS: 
Source: 
The study population needs to be selected from the outpatient sections of the Department 
of Periodontitis, TNGDC and Hospital, Chennai. 
SAMPLE SIZE : 20 
INCLUSION CRITERIA: 
 Patients with age group between 30-55 years. 
 Systemically healthy patients with clinical attachment level (CAL) ≥ 3mm in 
proximal sites of two non-adjacent teeth; bone loss confirmed by periapical 
radiographs; bleeding on probing (BOP) and probing depth (PD) 4-6mm. 
 Patients who have not undergone any type of regenerative periodontal therapy over 
a period of six months prior to the initial examination. 
 Patients without any antibiotic treatment in last three months. 
 Patients with established willingness and ability to perform adequate oral hygiene. 
EXCLUSION CRITERIA: 
 Patients who are suffering from any known systemic diseases or immune-
compromised 
 Patients who had received any surgical or non-surgical therapy six months prior to 
the start of the study 
 Patients who had received any antibiotic therapy in the last three months 
 Tobacco users and alcoholics were excluded 
 Pregnant and lactating females were not included in the study 
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SUBJECTS: 
 A total of 20 patients suffering from chronic periodontitis were divided into 2  
groups based on intervention with 10 patients in each group. Age group 30-55 
years. 
 Group I:      SRP only 
 Group II:  SRP + homeopathy drug ( Calcarea fluorica 30c ) 
STUDY DESIGN: 
The study is of randomized controlled trial type. The study participants will be recruited 
prospectively in this study. 
Sex: Either sex 
Ethical clearances were obtained from the Institutional Ethical Committee and ethical 
principles were meticulously followed throughout the study. After explaining the study 
protocol , informed consent was obtained from all the selected subjects . A thorough 
medical and dental history of the subjects was taken. All the subjects underwent full-mouth 
periodontal probing and charting and clinical and laboratory evaluation. 
METHOD OF COLLECTING DATA: 
Armamentarium: 
For Clinical Examination: 
 Mouth mirror 
 Williams  periodontal probe 
 Kidney tray 
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 Cotton roll 
 Sterilized disposable gloves, head cap, facemask 
For Phase I therapy: 
 Mouth mirror 
 Williams probe 
 Kidney tray 
 Cotton rolls 
 Sterilized disposable gloves, head cap, facemask 
 Disposable syringes 
 Local anaesthetic solution ( Lignocaine ) 
 Hu-Friedy Gracey Currettes 
For collection of blood sample  
 Sterile cotton.  
 Surgical spirit  
 Disposable syringe with 20 gauge needle. 
 Tourniquet.  
 
CLINICAL PARAMETERS ASSESSMENT  
 The following clinical parameters were evaluated for all the subjects:  
1. Plaque index – Silness and Loe 196480 
2. Gingival bleeding index – Ainamo and Bay 1975 81 
      3. Probing depth in mm (PD) – Carranza 10th ed 82 
      4. Clinical attachment level in mm (CAL) – Carranza 10th ed82 
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Plaque Index (Silness and Loe 1964)  
All teeth were examined at 4 sites each (disto-facial, facial, mesio-facial, lingual / palatal) 
and were scored as follows:  
Scoring Criteria:  
Score 0: No plaque in the gingival area.  
Score 1: A film of plaque adhering to the free gingival margin and adjacent area of the  
tooth. The plaque is recognized only by running a probe across the tooth surface.  
Score 2: Moderate accumulation of plaque within the gingival pocket and on the gingival  
margin and / or adjacent tooth surface that can be seen by the naked eye.  
Score 3: Abundance of soft deposits within the gingival pocket and / or on the gingival  
margin and adjacent tooth surface.  
Calculation:  
Plaque index per tooth = Total score/4  
Plaque index per individual ═ Total P I per tooth / Total number of teeth examined  
Interpretation:  
Score 0 – Excellent oral hygiene  
0.1 to 0.9 – Good oral hygiene  
1.0 to 1.9 – Fair oral hygiene  
2.0 to 3.0 - Poor oral hygiene
 
Gingival Bleeding Index (Ainamo & Bay 1975)  
Starting distobuccally, the probe was gently inserted into the sulcus and run to the  
buccal and mesial surfaces of every tooth at an angle of about 45º. This was repeated for 
all the teeth present. Similarly probing was carried out at palatal/lingual sites. The total 
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number of bleeding sites per tooth was thus recorded for every tooth except the third 
molar.  
Scoring Criteria:  
Positive score (1) - Presence of bleeding within 10 seconds  
Negative score (0) - Absence of bleeding 
  
% of bleeding sites =  Total number of positive score x 100  
Total number of surfaces of all teeth 
Probing Pocket Depth (PPD)  
Probing Pocket Depths were measured from the gingival margin to the base of the pocket 
in millimeters using William’s Periodontal Probe. The probe was walked within the 
gingival sulcus along the circumference of the tooth. Keeping the probe parallel to the long 
axis of the selected tooth, six measurements were made per tooth (Mesiobuccal, 
Distobuccal, Midbuccal, Mesiolingual, Distolingual and Midlingual). 
Clinical Attachment Level (CAL) 
Clinical Attachment Level was measured from the Cemento – Enamel Junction (CEJ) to 
the base of the pocket using William‘s Periodontal Probe.  
When the gingival margin was located on the anatomic crown, the level of the attachment 
was determined by subtracting from the probing depth, the distance from the gingival 
margin to the CEJ. If both were the same, the loss of attachment was calculated to be zero.  
When the gingival margin coincided with the CEJ, the loss of attachment was calculated as 
equaling the probing depth.  
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When the gingival margin was located apical to the CEJ, the loss of attachment was greater 
than the probing depth and therefore the distance between the CEJ and the gingival margin 
were added to the PD.  
Three measurements were made on the buccal aspect and three on the lingual aspect of 
each tooth – total of six sites per tooth ( Mesiobuccal, Midbuccal, Distobuccal, 
Mesiolingual, Midlingual, and Distolingual). 
 
 
ESTIMATION OF OSTEOPONTIN 
METHOD OF COLLECTION OF BLOOD SAMPLE 
Venous blood was drawn from the participants selected for the study. The subjects were 
informed, and consent was taken. They were made to tighten a fist so that vein was more 
palpable, and antecubital vein was selected for venipuncture. A tourniquet was applied 
about 1-2 inches above the antecubital fossa. After cleansing the puncture site with 10% 
isopropanol solution, blood was withdrawn using a syringe with 24 gauge needle. 
Tourniquet was released as the blood flow began. After drawing 3 ml of blood, sterile 
cotton ball was placed on the puncture site and needle was withdrawn. The subjects were 
instructed to apply mild finger pressure on the site for few minutes to avoid oozing out of 
blood. 
Quantitative determination of osteopontin in patient's plasma was done by enzyme-linked 
immunosorbent assay (ELISA) method. 
 
Materials and Methods 
 
 Page 30 
 
PRINCIPLE OF THE ASSAY 
The kit uses a double-antibody sandwich enzyme-linked immunosorbent assay (ELISA) to 
assay the level of human osteopontin (OPN) in samples. Osteopontin ( OPN ) was added to 
monoclonal antibody enzyme well which was pre-coated with human osteopontin 
monoclonal antibody. This was incubated and then osteopontin antibodies labeled with 
biotin was added and combined with Streptavidin-HRP to form  immune complex. 
Incubation was carried out and  washed again to remove the uncombined enzyme. To this 
chromogen solution A, B was added which resulted in change of color to blue and at the 
effect of acid, the color changed to yellow. The chroma of color and the concenthumanion 
of the human plasma osteopontin sample were positively correlated. 
OSTEOPONTIN DETERMINATION 
PROCEDURE 
1. All reagents were brought to room temperature before use. 
2. Standard no.5 (48ng/ml) in duplicate  
Standard no.4 (24ng/ml) in duplicate 
Standard no.3 (12ng/ml) in duplicate 
Standard no.2 (6ng/ml) in duplicate 
Standard no.1 (3ng/ml) in duplicate , were pipette out. 
3. Inject samples:① Blank well: no samples or OPN-antibody labeled with biotin, 
Streptavidin-HRP were added, only Chromogen solution A and B, and stop 
solution were allowed; other operations were the same.② Standard wells:  standard 
50μl, Streptavidin-HRP 50μl (since the standard already has combined  biotin 
antibody, it was not necessary to add the antibody) were added;③ To be test wells:  
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sample 40μl, was added and then  both OPN-antibody 10μl and Streptavidin-HRP 
50μl were added. Then sealing memberance was sealed, gently shaken and 
incubated for 60 minutes at 37 ℃. 
4. Confection: 30×washing concentrate was diluted 30 times with distilled water as 
standby. 
5. Washing: The memberance was removed carefully, the liquid drained and the 
remaining water was shook away.  
6. Chromogen solution A 50μl, then chromogen solution B 50μl were added to each 
well, gently mixed and incubated for 10 min at 37℃ away from light. 
7.  Stop: Stop Solution 50μl was added into each well to stop the reaction (the blue 
changes into yellow immediately).  
8. Final measurement: after taking blank well as zero, the optical density (OD) was 
measured under 450 nm wavelength which was carried out within 15min after 
adding the stop solution. 
9. According to standards’ concentration and the corresponding optical density values, 
the standard curve linear regression equation was calculated. The optical density 
values of the sample were applied on the regression equation and the corresponding 
sample’s concentrations were calculated. 
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SUMMARY 
Patient blood sample collected 
 
 
 
Sample added to microtitre wells 
 
 
 
Preparing reagents and standards 
 
 
 
Add prepared samples and standards, antibodies labeled with enzyme, reacting 60 minutes 
at 37 ℃ 
 
 
 
Plate washed five times, adding Chromogen solution A, B, reacting 10 minutes at 37 ℃ 
 
 
 
Add stop solution measure the optical density value within 10min 
 
 
Calculation 
 
 
DRUG USED IN THE STUDY 
Calcarea fluorica (30c) : 
Calcarea fluorica, also called calcium fluoride, fluoride of lime, calcii 
fluoridum or fluorspar, is a naturally occurring mineral. Calcium fluoride is an 
important mineral for teeth and bones and is also found in the tissue fibers that 
make up skin, vessel walls and connective tissue. It prevents unnatural looseness of 
teeth, with or without pain thus prevent tooth loosening in the socket. Also used for 
gum-boil, with hard swelling on the jaw, cracked appearance of the tongue, with or 
without pain, induration of tongue, hardening after inflammation and for toothache 
with pain if any tooth touches the tooth. It is a powerful tissue remedy for hard 
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stony glands, varicose and enlarged veins and malnutrition of bones. Also used for 
hard swellings on the cheek with pain or toothache and hard swellings on jaw bone. 
It is useful for building the health and strength of teeth and bones during childhood, 
and after a serious injury to the bones, especially a fracture. It is also helpful for 
lumps that develop on bones (after a bad bruise to a bone or a fracture) or around 
joints (after a bad sprain).   
 
 
Photograph 1: Calcarea Fluor 
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Photograph 2 : Group I Patient Before Therapy 
 
Photograph 3 : Group I Patient 3 Months After Therapy 
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Photograph 4 : Group II Patient Before Therapy 
 
Photograph 5 : Group II Patient 3 Months After Therapy 
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Photograph 6 : Armamentarium for blood collection 
 
 
Photograph 7 : Collection of venous blood sample 
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Photograph 8 : Armamentarium for phase I therapy 
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Photograph 9 : ELISA Reader 
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STATISTICAL ANALYSIS 
 In the present interventional study, 20 subjects with generalized chronic 
periodontitis were included, 10 among them were categorized as Group I and the other 10 
were categorized as Group II.  There were 5 females and 5 males in each group, with a 
mean average of 39.40± 6.89 years in Group I, 38.06 ± 8.25years in Group II. The 
parameters assessed were plaque index, gingival bleeding index, probing depth, clinical 
attachment level (clinical) and serum osteopontin level (laboratory) at baseline and 3 
months post-operatively.  
The statistical analysis was done using the computer software program SPSS version 16.0 
(Statistical Package for Social Science, Version 16). 
Statistical Tests used: 
1. Independent sample test – For inter group analysis 
2. Chi-Square test -  For gingival bleeding index 
3. Paired Sample test – For intragroup analysis 
4. Pearsons Correlation test – For correlation 
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RESULTS 
1. PLAQUE INDEX  
Intragroup comparison  
Group I: The mean plaque index score at baseline was 2.42± 0.23 and at 3 months was  
0.99 ±0 .27. The mean difference in plaque score from baseline to 3 month was statistically 
significant (p=0.000).  
Group II: The mean plaque index score at baseline was 2.45 ± 0.31 and at 3 months was  
1.04 ± 0.32. The mean reduction in plaque score from baseline to 3 months was 
statistically significant (p=0.000).  
Intergroup comparison  
Mean difference between group I and group II at baseline was -0.027 which was 
statistically not significant (p=0.831) and at 3 months post-op was -0.055 which was also 
statistically insignificant (p=0.685).  
 
2. PROBING POCKET DEPTH  
Intragroup comparison  
Group I: The mean PPD at baseline was 3.66 ±1.06 and at 3 months was 2.64 ±0.76. The 
mean reduction in PPD from baseline to 3 months was statistically significant (p=0.003).  
Group II: The mean PPD at baseline was 3.84±0.62 and at 3 months was 2.09±0.72. The 
mean reduction in PPD from baseline to 3 months was statistically significant (p=0.000).  
Intergroup comparison  
Mean difference between group I and group II at baseline was -0.18 which was statistically 
non-significant (p=0.649) and at 3 months post-op was 0.55 which was statistically non-
significant (p=0.115).  
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3. CLINICAL ATTACHMENT LEVEL  
Intragroup comparison  
Group I: The mean CAL at baseline was 3.97 ±1.10 and at 3 months was 3.01±0.97. The 
mean reduction in CAL from baseline to 3 months was statistically significant (p=0.006).  
Group II: The mean CAL at baseline was 4.25 ±0.72 and at 3 months was 2.89±0.65. The 
mean reduction in CAL from baseline to 3 months was statistically significant (p=0.000).  
 
Intergroup comparison  
Mean difference between group I and group II at baseline was -0.28 which was statistically 
non-significant (p=0.506) and at 3 months post-op was 0.116 which was statistically non-
significant (p=0.757). 
 
4.OSTEOPONTIN 
Intragroup comparison  
Group I: The mean osteopontin at baseline was 1.263±9.97 and at 3 months was 
1.047±6.35. The mean reduction in serum osteopontin from baseline to 3 months was 
statistically significant (p=0.000).  
Group II: The mean serum osteopontin at baseline was 1.261 ±8.69 and at 3 months was 
1.046±8.27. The mean reduction in serum osteopontin from baseline to 3 months was 
statistically significant (p=0.000). 
Intergroup comparison  
Mean difference between group I and group II at baseline was 1.60 which was statistically 
not significant (p=0.707) and at 3 months post-op was 0.500 which was statistically non-
significant (p=0.881). 
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TABLE 1 : MASTER CHART – GROUP 1 ( CLINICAL PARAMETERS ) 
 
S. 
NO 
 
AGE 
 
 
SEX 
 
 
BASELINE 
PI 
 
BASELINE 
PPD 
 
BASELINE 
CAL 
 
BASELINE 
GBI 
 
3MONTH PI 
 
3MONTH 
PPD 
 
3MONTH 
CAL 
 
3MONTH 
GBI 
1.  45 F 2.56 5.13 5.78 1 0.67 3.34 3.65 0 
2.  42 M 2.53 4.17 4.21 1 0.57 2.17 2.56 1 
3.  31 M 2.23 3.88 4.60 1 1.08 2.03 2.12 0 
4.  39 M 2.30 4.51 4.60 1 1.01 3.26 4.33 0 
5.  40 M 2.57 3.68 4.11 1 1.24 3.13 3.86 0 
6.  42 F 2.34 4.26 4.36 1 1.21 2.83 3.39 0 
7.  34 F 2.46 2.42 3.01 1 0.68 2.90 2.98 0 
8.  29 M 1.98 1.46 1.61 1 1.05 0.85 0.90 0 
9.  44 F 2.86 3.18 3.48 1 1.42 2.80 3.08 0 
10.  32 F 2.40 3.96 4.01 1 1.01 3.11 3.18 0 
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TABLE 2: MASTER CHART – GROUP II (CLINICAL PARAMETERS ) 
 
S. NO 
 
AGE 
 
 
SEX 
 
 
BASELINE 
PI 
 
BASELINE 
PPD 
 
BASELINE 
CAL 
 
BASELINE 
GBI 
 
3MONTH 
PI 
 
3MONTH 
PPD 
 
3MONTH 
CAL 
 
3MONTH 
GBI 
1.  28 F 2.44 3.92 4.25 1 0.55 1.23 3.52 0 
2.  44 M 2.33 2.89 3.18 1 0.57 1.18 2.28 1 
3.  31 M 2.30 5.01 5.65 1 1.10 3.54 3.88 0 
4.  34 F 2.33 4.20 4.90 1 1.05 2.21 3.08 0 
5.  32 F 2.87 3.56 3.99 1 1.44 1.38 2.25 0 
6.  30 M 2.45 3.28 3.66 1 1.36 1.88 2.03 0 
7.  32 F 2.85 3.89 4.04 1 1.44 2.08 2.53 0 
8.  38 M 1.66 4.42 4.67 1 0.90 2.57 2.95 1 
9.  45 M 2.50 3.27 3.61 1 1.10 2.29 2.68 0 
10.  38 F 1.77 4.02 4.55 1 0.97 2.55 3.69 0 
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TABLE 3 : MASTER CHART – GROUP I ( LABORATORY PARAMETER ) 
 
S. NO 
 
AGE 
 
SEX 
 
BASELINE OSTEOPONTIN 
 
3 MONTH POST-OP 
OSTEOPONTIN 
1.  45 F 1250 1038 
2.  42 M 1274 1052 
3.  31 M 1254 1039 
4.  39 M 1280 1058 
5.  40 M 1265 1048 
6.  42 F 1253 1042 
7.  34 F 1255 1044 
8.  29 M 1267 1050 
9.  44 F 1265 1049 
10.  32 F 1270 1052 
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TABLE 4 : MASTER CHART – GROUP II ( LABORATORY PARAMETER ) 
 
S. NO 
 
AGE 
 
SEX 
 
BASELINE OSTEOPONTIN 
 
3 MONTH POST-OP 
OSTEOPONTIN 
1.  28 F 1252 1036 
2.  44 M 1273 1057 
3.  31 M 1258 1046 
4.  34 F 1275 1058 
5.  32 F 1268 1049 
6.  30 M 1269 1056 
7.  32 F 1255 1042 
8.  38 M 1252 1035 
9.  45 M 1258 1045 
10.  38 F 1257 1043 
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TABLE 5 : COMPARISON OF PLAQUE SCORES 
GROUPS BASELINE 3 MONTHS POST-OP P VALUE 
GROUP I 2.42 ± 0.235 0.993 ± 0.275 0.000 
GROUP II 2.45 ± 0.315 1.048 ± 0.318 0.000 
 
 
 
TABLE 6 : COMPARISON OF GINGIVAL BLEEDING INDEX 
GROUPS 
 
BASELINE 3 MONTH POST-OP P VALUE 
 ABSENCE PRESENCE ABSENCE PRESENCE 
GROUP I 0 10 9 1 0.000 
GROUP II 0 10 8 2 0.001 
 
 
 
TABLE 7 : COMPARISON OF PROBING POCKET DEPTH 
GROUPS BASELINE 3 MONTH POST-OP P VALUE 
GROUP I 3.665 ± 1.067 2.64 ± 0.764 0.003 
GROUP II 3.846 ± 0.623 2.091 ± 0.723 0.000 
 
Results 
 
 Page 47 
 
 
 
 
 
TABLE 8 : COMPARISON OF CLINICAL ATTACHMENT LEVEL 
GROUPS BASELINE 3 MONTH POST-OP P VALUE 
GROUP I 3.967 ± 1.103 3.005 ± 0.971 0.006 
GROUP II 4.250 ± 0.719 2.889 ± 0.645 0.000 
 
 
 
 
TABLE 9 : COMPARISON OF OSTEOPONTIN LEVEL 
GROUPS BASELINE 3 MONTH POST-OP P VALUE 
GROUP I 1.263 ± 9.978 1.047 ± 6.356 0.000 
GROUP II 1.261 ± 8.692 1.046 ± 2.616 0.000 
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INTERGROUP ANALYSIS USING INDEPENDENT SAMPLES TEST 
TABLE 10 : PLAQUE SCORE 
Dependent 
Variable 
Mean 
difference 
Std. Error Sig. 95% confidence level 
Lower 
Bound 
Upper 
Bound 
Baseline  
Plaque score 
-0.2700 0.124 0.831 -0.288 0.234 
3 month  
Plaque score 
-0.055 0.133 0.685 -0.334 0.224 
Difference  
Plaque score 
0.028 0.151 0.856 -0.290 0.346 
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TABLE 11 : GINGIVAL BLEEDING INDEX 
Dependent 
Variable 
Mean 
difference 
Std. Error Sig. 95% confidence level 
Lower 
Bound 
Upper 
Bound 
Baseline  
Gingival bleeding 
index 
-0.055 0.126 0.668 -0.319 
 
0.209 
3 month  
Gingival bleeding 
index 
-0.109 0.073 0.153 -0.262 0.044 
Difference  
Gingival bleeding  
Index 
0.054 0.884 0.549 -0.131 0.239 
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TABLE 12 : PROBING POCKET DEPTH 
Dependent 
Variable 
Mean 
difference 
Std. Error Sig. 95% confidence level 
Lower 
Bound 
Upper 
Bound 
Baseline  
PPD 
-0.181 0.390 0.649 -1.002 
 
0.640 
3 month  
PPD 
0.551 0.332 0.115 -0.148 1.250 
Difference PPD -0.732 0.289 0.021 -1.340 -0.123 
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TABLE 13 : CLINICAL ATTACHMENT LEVEL 
Dependent 
Variable 
Mean 
difference 
Std. Error Sig. 95% confidence level 
Lower 
Bound 
Upper 
Bound 
Baseline  
CAL 
-0.283 0.416 0.506 -1.158 
 
0.592 
3 month  
CAL 
0.116 0.368 0.757 -0.659 0.891 
Difference CAL -0.399 0.301 0.203 -1.032 0.234 
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TABLE 14 : OSTEOPONTIN 
Dependent 
Variable 
Mean 
difference 
Std. Error Sig. 95% confidence level 
Lower 
Bound 
Upper 
Bound 
Baseline  
Ostepontin 
1.600 4.184 0.707 -7.192 
 
10.392 
3 month  
Ostepontin 
0.500 3.299 0.881 -6.431 7.431 
Difference in 
Osteopontin 
1.100 1.464 0.462 -1.975 4.175 
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TABLE 15 : GROUP I CORRELATION 
 
Correlations 
  PI 
(3mnths) 
GBI 
(3mnths) 
PPD 
(3mnths) 
CAL 
(3mnths) 
OPN 
(3mnths) 
PI3mnths Pearson 
Correlation 
1 .143 -.010 .059 .092 
Sig. (2-tailed)  .694 .978 .872 .801 
N 10 10 10 10 10 
GBI3mnths Pearson 
Correlation 
.143 1 .428 .368 .025 
Sig. (2-tailed) .694  .217 .295 .945 
N 10 10 10 10 10 
PPD3mnths Pearson 
Correlation 
-.010 .428 1 .952
**
 -.020 
Sig. (2-tailed) .978 .217  .000 .955 
N 10 10 10 10 10 
CAL3mnths Pearson 
Correlation 
.059 .368 .952
**
 1 .132 
Sig. (2-tailed) .872 .295 .000  .716 
N 10 10 10 10 10 
OPN3mnths Pearson 
Correlation 
.092 .025 -.020 .132 1 
Sig. (2-tailed) .801 .945 .955 .716  
N 10 10 10 10 10 
**. Correlation is significant at the 0.01 level (2-tailed).    
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TABLE 16 : GROUP II CORRELATION 
 
Correlations 
  PI 
(3mnths) 
GBI 
(3mnths) 
PPD 
(3mnths) 
CAL 
(3mnths) 
OPN 
(3mnths) 
PI3mnths Pearson 
Correlation 
1 .146 .238 -.385 .180 
Sig. (2-tailed)  .688 .508 .272 .618 
N 10 10 10 10 10 
GBI3mnths Pearson 
Correlation 
.146 1 .265 -.009 .154 
Sig. (2-tailed) .688  .460 .980 .671 
N 10 10 10 10 10 
PPD3mnths Pearson 
Correlation 
.238 .265 1 .586 -.205 
Sig. (2-tailed) .508 .460  .075 .571 
N 10 10 10 10 10 
CAL3mnths Pearson 
Correlation 
-.385 -.009 .586 1 -.471 
Sig. (2-tailed) .272 .980 .075  .169 
N 10 10 10 10 10 
OPN3mnths Pearson 
Correlation 
.180 .154 -.205 -.471 1 
Sig. (2-tailed) .618 .671 .571 .169  
N 10 10 10 10 10 
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Figure 1 : Comparison of plaque index between group I and group II 
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Figure 2 : Comparison of gingival bleeding index between group I and group II 
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Figure 3 : Comparison of  Probing pocket depth between group I and group II 
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Figure 4 : Comparison of Clinical attachment level between group I and group II 
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Figure 5 : Comparison of osteopontin level between group I and group II 
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DISCUSSION 
 
 Periodontitis is an inflammatory disease of the supporting tissues surrounding the 
teeth caused by heterogenous group of microorganisms, resulting in progressive 
destruction of the periodontal ligament, which if left untreated will progress to alveolar 
bone destruction ultimately resulting in tooth loss ( Marugame et al 2003)
83
.  
The sine qua non of periodontal treatment is to preserve the dentition. Ideally, 
therapy should resolve inflammation, arrest disease progression, maintain aesthetics, 
maximize patient comfort, regenerate lost periodontium and create an environment that 
deters recurrent disease. To accomplish these goals both surgical and non-surgical 
procedures are employed. To date, the critical objective of periodontal therapy has been to 
halt disease progression. In this regard, clinical trials indicate that scaling and root planing 
can arrest periodontitis (Badersten et al 1987, Philstrom et al 1981, Philstrom et al 1984, 
AAP 1989)
84,52,54,72 
.  
Numerous studies indicated mechanical instrumentation improved periodontal 
status (Listgarten et al 1978, Caffesse et al,1986 )
85,86
 . After mechanical instrumentation, 
probing depth reduction results from gingival recession and a gain of clinical attachment 
(Hughes & Caffesse 1978, Proye et al 1982)
42,43
. In general, the deepest sites 
demonstrated the greatest pocket reduction after instrumentation ( Knowles 1979, 
Hammerle et al 1991 )
87,88
. Similarly, the magnitude of recession was related to initial 
probing depths and inflammatory status of the tissues. The most gingival shrinkage 
occurred interproximally. After scaling and root planing, investigators reported decreased 
gingival inflammation and less bleeding upon probing in patients with chronic 
periodontitis (Singletary et al 1982, Greenewell  et al 1984, Lavanchy et al 1987)
39,40,41
. 
Discussion 
 
 Page 61 
 
This study was conducted to evaluate the efficacy of homeopathy medicine as an 
adjunct to scaling and root planning in patients with chronic periodontitis. The medicine 
used here was Calcarea fluor 30s. Even though it has been used to evaluate the 
remineralization efficacy on artificial carious lesions on enamel the present study is the 
only study till date to access the effectiveness of calc-f tablets on periodontium. 
In the present study, subjects with any acute or chronic systemic conditions like 
diabetes or inflammatory conditions like rheumatoid arthritis, cardiovascular diseases etc. 
had been excluded because these conditions can cause increased osteopontin level on their 
own, which may lead to confounding effect in the study.  
Patients under medications like antibiotics, corticosteroids or anti-inflammatory 
drugs for the past 3 months and those underwent periodontal therapy within the past six 
months have also been excluded because these therapies can suppress the inflammatory 
process and may lead to confounding effect in the study. 
Quantitative determination of osteopontin in the present study in both groups was 
done by double antibody sandwich ELISA method which is a very sensitive method for 
comparing osteopontin.  
In the present study two groups with 10 patients each having chronic periodontitis 
were evaluated. In group I, the patients underwent scaling and root planning alone while in 
group II scaling and root planning was accompanied by systemic administration of calcarea 
fluor for 3 months. The clinical parameters like gingival bleeding index, plaque index, 
pocket probing depth and clinical attachment level were measured for each group at 
baseline and 3 months after therapy. Also comparison of osteopontin level was done 
between the two groups before and after therapy.  
 Bleeding on probing is a commonly used diagnostic criterion for periodontal 
diseases. A highly significant reduction was observed in both group I (p =0.00) and group 
Discussion 
 
 Page 62 
 
II (p = 0.001) before and after therapy. The sustained reduction in bleeding on probing is of 
practical interest because the lack of bleeding is a reasonable prognosticator of periodontal 
health. Stability is anticipated when bleeding is reduced. 
Plaque scores reflect the oral hygiene status of the patient than the disease severity. 
Plaque index in group I was 2.42 ± 0.23 at baseline which had decreased to .993 ± 0.275 , 
3 months after therapy, which  showed a statistically significant result. In group II, the 
plaque index was 2.45 ± 0.31 at baseline 1.048 ± 0.318 post-treatment, which also showed 
a statistically significant result. But there was no statistically significant difference between 
group I and group II after therapy.  
 Probing pocket depth measurements are of prime importance in evaluationg the 
success of a periodontal therapy. The probing pocket depth in group I was 3.66 ±1.06 at 
baseline and 2.64 ± 0.764 after therapy. This showed a statistically significant difference 
and the results are consistent with the studies done by Lindhe et al 1982
56
. In their split 
mouth study comparing scaling and root planning to modified Widman flap, they found 
that the pocket depth reduced from 4.2 to 2.9mm in the SRP group. Numerous other 
studies by Philstrom et al. (1981, 1983,1984 )
52,53,54
, Hill et al. (1981)
55
, Kerry et al. 
(1990) 
63 
also showed a statistically significant reduction in probing depth before and after 
scaling and root planing. The probing depth in group II was 3.84±0.62 at baseline and 
2.091 ±0.723 after use of homeopathy medicine along with scaling and root planning. This 
result showed a statistically significant difference between group I and group II, 3 months 
after therapy (0.021). 
 Change in clinical attachment level denotes the status and condition of the tissues. 
The clinical attachment level in group I was 3.97 ±1.10 at baseline and 3.005 ± 0.971, 3 
months after the phase I therapy. This shows a statistically significant reduction in 
attachment level which correlates with the studies conducted by Cobb 1996
46
, Becker et al 
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1988
64
, Isidor et al (1984,1985)
59,60
, Isidor and Karring (1986)
61
.  In group II the 
reduction was from 4.25 ±0.72 at baseline to 2.889 ± 0.645 after therapy. Though there 
was no statistically significant difference between group I and group II after therapy, the 
reduction was more evident in group II.  
 The present study showed significantly higher levels of osteopontin in group I 
(mean 1263.30ng/ml) at baseline as compared to 3 months after treatment (1047.2ng/ml) . 
Group II also showed almost the same values at baseline (1261.7ng/ml) and post-therapy 
(1046.7ng/ml ). The result correlates with the findings of Hans and Mali (2012)
89
 who 
observed statistically significant decrease in osteopontin level between baseline and 2 
months after phase I therapy (153.09ng/ml, 91.52ng/ml). In their study assessment of 
osteopontin was done using Osteopontin enzyme immunometric assay kit whereas in the 
present study the analysis was done using sandwich type human osteopontin enzyme 
immunoassay kit. But there was no statistically significant difference between group I and 
group II in osteopontin level before and after therapy. The result of the present study was 
similar to the result obtained by Sharma and Pradeep (2007)
31
. The highest mean gingival 
crevicular fluid level of OPN in periodontitis subjects in their study was 1575.01 ng/ml and 
after phase I therapy it decreased to 1194.80 ng/ml. The OPN level in plasma was 1273.21 
ng/ml which decreased to 1051.68 ng/ml after phase I therapy. 
 The present study was conducted to evaluate if  homeopathy treatment improved 
the results of phase I therapy in chronic periodontitis patients. Though plaque index, 
gingival bleeding index, CAL and osteopontin level showed no statistically significant 
difference, there was a significant difference in PPD between group I and group II. More 
research with a larger sample size may yield a better result and will help to evaluate the 
effectiveness of this homeopathy medicine in dental field. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Summary and Conclusion 
 
 
Summary and Conclusion 
 
 Page 64 
 
SUMMARY AND CONCLUSION 
  
The present study was conducted in order to evaluate the effectiveness of calcarea 
fluor as an adjunct to scaling and root planning in patients with chronic periodontitis. 
A total of 20 patients with chronic periodontitis were selected and divided into two 
groups of 10 each. Group I patients were treated with scaling and root planning alone while 
group II patients were given calcarea fluor for 3 months after scaling and root planning. 
The clinical parameters and osteopontin analysis were done at baseline and 3 months after 
therapy and thevalues were subjected to statistical analysis. 
The following conclusions were drawn from the study:  
 The osteopontin levels are high in patients with chronic periodontitis and the value 
show appreciable reduction after phase I therapy. 
 Even though clinical parameters show a considerable improvement after phase I 
therapy, there is no appreciable difference after use of calcarea fluor except for 
probing pocket depth. 
In future, clinical interventional studies with larger sample size may be employed 
to further evaluate the efficacy of  calcarea fluor as an adjunct for treating periodontal 
diseases and maintaining and improving  oral health status of the patient. 
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Annexure 1 : Participant information sheet ( English ) 
 
Participant information sheet 
Investigator : Anju M K Guide : K. Malathi, MDS  
Title : CLINICAL AND BIOCHEMICAL EVALUATION OF EFFICACY OF CALCIUM 
FLUORIDE AS AN ADJUNCT TO NON-SURGICAL PERIODONTAL THERAPY – A 
RANDOMIZED CLINICAL TRIAL  
Name of the research institution : Tamilnadu Government Dental College and Hospital, 
Chennai  
The investigator, Dr. ANJU M K under the guidance of Dr. K MALATHI, MDS and  
Dr. V.S. PARTHIBAN, DHMS is conducting a study as titled above with aim to do an 
evaluation of calcium fluoride usage along with scaling and root planning in chronic 
periodontitis.  
1. Procedure : the following examinations and investigations will be done for you.  
 Intraoral examination, Extraoral examination 
 Blood test – 7ml of blood will be drawn from your hand  
 X-ray will be taken for the diseased site  
 Model of your teeth will be prepared by taking alginate impression 
 Deposits on your teeth with ultrasonic scaler and hand instrument. Homeopathy drug may or 
may not be given to the patient. Further clinical evaluation will be performed at baseline, 3 
months and 6 months after the procedure. 2ml of blood will be drawn again at 6 months.  
2. Risk of participation:  
 Patients may be allergic to LA or the material used in the study. 
 Patient may experience pain, discomfort, swelling following the procedure. 
3. Benefits of participation:  
 
Patients will be treated for improving the periodontal status and minimizing alveolar bone loss.  
4. Confidentiality :  
 
The identity of the patients participating in the research will be kept confidential throughout 
the study. In the event of any publication or presentation resulting from the research, no 
personally identifiable information will be shared.  
5. Participants right :  
 
Taking part in the study is voluntary. You are free to decide whether to participate in the study 
or to withdraw at any time; your decision will not result in any loss of benefits to which you 
are otherwise entitled. The results of this study will be intimated to you at the end of the study 
period or during the study if anything is found abnormal which may aid in the management or 
treatment.  
6. Compensation: Nil  
7. Contacts:  
For queries related to the study:  
Primary Investigator: Dr.ANJU M K  
Contact Details: PG Student  
Department of Periodontics  
Tamilnadu Govt. Dental College & 
Hospital  
Chennai-600 003.  
Phone number:7200909002  
 
Contact details regarding rights of the 
participant:  
Dr. B. Saravanan, MDS,PhD,  
The Chairperson,  
Institutional Ethical committee  
Tamilnadu Govt. Dental College & 
Hospital, Chennai-600 003.  
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Annexure 2 : Participant information sheet ( Tamil ) 
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Annexure 3 : Informed Consent Form (English) 
 
Informed Consent Form 
 
CLINICAL AND BIOCHEMICAL EVALUATION OF EFFICACY OF 
CALCIUM FLUORIDE AS AN ADJUNCT TO NON-SURGICAL PERIODONTAL 
THERAPY – A RANDOMIZED CLINICAL TRIAL 
 
Participant ID No: 
 
“I have read the foregoing information, or it has been read to me. I have had the 
opportunity to ask questions about it and any questions I have asked have been answered 
to my satisfaction. I consent voluntarily to participate as a participant in this study and 
understand that I have the right to withdraw from the study at any time without in any way 
it affecting my further medical care.” 
 
 
_______________               _________________                  __________________ 
Date                                          Name of the participant            Signature/thumb impression     
                                                                                                             Of the participant   
 
 
[The literate witness selected by the participant must sign the informed consent form. 
The witness should not have any relationship with the research team; If the participant 
doesn’t want to disclose his / her participation details to others, in view of respecting the 
wishes of the participant, he / she can be allowed to waive from the witness procedure 
(This is applicable to literate participant ONLY). This should be documented by the 
study staff by getting signature from the prospective participant] 
 
_________________________________________________________________________
____________________________ 
 
__________________________   
 
 
“I have witnessed the accurate reading of the consent form to the potential participant and 
the individual has had opportunity to ask questions. I confirm that the individual has given 
consent freely” 
 
 
______________                   __________________                       ___________________ 
Date                                           Name of the witness                                Signature of the witness 
 
 
______________                      ___________________                  __________________ 
Date                                          Name of the interviewer                    Signature of the interviewer  
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Annexure 4 : Informed Consent Form (Tamil) 
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Annexure 5 : Proforma 
PROFORMA FOR TREATMENT GROUP 
 
Date  :     OP No.:    S.No.: 
Name :     Age :    Sex: 
Occupation :    Income :      
Address  :      Phone Number :  
 
 
 
CHIEF COMPLAINTS AND DURATION: 
 
 
HISTORY OF PRESENT ILLNESS: 
 
 
PAST MEDICAL HISTORY: 
 
 
PAST DENTAL HISTORY: 
 
 
FAMILY HISTORY : 
 
 
PERSONAL HISTORY : 
a) Oral Hygiene Practices : 
b) Habits          : 
Annexures 
 
 Page 80 
 
c) Menstrual History          : 
d) Menopause          : 
 
e) H/o. Stress Factor         : 
 
 
GENERAL EXAMINATION  
a) Extra-Oral Examination 
 
 
b) Examination of Lymphnodes  
 
INTRA-ORAL EXAMINATION WITH CLINICAL FINDINGS: 
Buccal mucosa: 
Vestibule: 
Hard palate: 
Soft palate: 
Tonsils: 
Tongue: 
Floor of the mouth: 
 
Teeth: 
Decayed 
Missed 
Filled teeth 
 
Gingiva: 
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Plaque index 
                
18 17 16 15 14 13 12 11 21 22 23 24 25 26 27 28 
48 47 46 45 44 43 42 41 31 32 33 34 35 36 37 38 
                
 
 
Bleeding Index 
                
18 17 16 15 14 13 12 11 21 22 23 24 25 26 27 28 
48 47 46 45 44 43 42 41 31 32 33 34 35 36 37 38 
                
 
 
Probing depth and attachment level  in millimeter: 
Maxillary: 
CAL                 
PPD                 
 18 17 16 15 14 13 12 11 21 22 23 24 25 26 27 28 
PPD                 
CAL                 
 
 
Mandibular: 
CAL                 
PPD                 
 18 17 16 15 14 13 12 11 21 22 23 24 25 26 27 28 
PPD                 
CAL                 
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Investigations: 
1. Biochemical / Haematological Investigation : 
Hb count  
Total Leucocyte Count  
Differential Leucocyte Count  
Bleeding Time  
Clotting Time  
Random Blood Sugar 
2. Osteopontin level 
3. Others : 
Blood Pressure : 
Test Dose for L.A: 
 
RADIOGRAPHIC EVALUATION  
Intra-Oral Periapical Radiograph/Orthopantomogram (IOPA/OPG) 
 
 
 
PROVISIONAL DIAGNOSIS 
 
PROGNOSIS  
 
TREATMENT PLAN 
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FITNESS FOR TREATMENT  
 
TREATMENT DONE  
 
DATE :   PROCEDURE :   SIGNATURE : 
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MAINTENANCE PHASE 
EVALUATION AFTER - 3 MONTH 
Osteopontine level :  
 
Gingiva 
Plaque index 
                
18 17 16 15 14 13 12 11 21 22 23 24 25 26 27 28 
48 47 46 45 44 43 42 41 31 32 33 34 35 36 37 38 
                
 
Bleeding index 
                
18 17 16 15 14 13 12 11 21 22 23 24 25 26 27 28 
48 47 46 45 44 43 42 41 31 32 33 34 35 36 37 38 
                
 
 
Probing depth and attachment loss in millimeter: 
Maxillary: 
CAL                 
PPD                 
 18 17 16 15 14 13 12 11 21 22 23 24 25 26 27 28 
PPD                 
CAL                 
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Mandibular 
CAL                 
PPD                 
 48 47 46 45 44 43 42 41 31 32 33 34 35 36 37 38 
PPD                 
CAL                 
 
 
 
 
 
 
 
SIGNATURE OF THE P.G.                                      SIGNATURE OF THE PROFESSOR 
 
DATE: 
 
 
